Table 2.
Analytes | Linear Range µg·mL–1 |
Calibration Curve | R2 | ANOVA p Value |
LLOD µg·mL–1 |
LLOQ µg·mL–1 |
---|---|---|---|---|---|---|
Coptisine | 9.37–468.72 | Y = 2225.6x − 5608.1 | 0.9998 | 0.0000 | 0.63 | 2.10 |
Epiberberine | 6.75–337.50 | Y = 2120.9x − 3536 | 0.9998 | 0.0000 | 0.81 | 2.16 |
Columbamine | 3.56–142.22 | Y = 2.3547x − 0.6865 | 0.9997 | 0.0000 | 0.81 | 2.71 |
Jatrorrhizine | 5.96–298.04 | Y = 3.3457x − 7.1431 | 0.9999 | 0.0000 | 0.62 | 1.85 |
Berberine | 23.63–1181.70 | Y = 3358x − 12774 | 0.9998 | 0.0000 | 0.53 | 1.60 |
Palmatine | 7.88–394.08 | Y = 3696.4x − 3244 | 0.9998 | 0.0000 | 0.31 | 0.92 |
Dehydroevodiamine | 4.30–85.92 | Y = 3.026x − 1.9044 | 0.9999 | 0.0000 | 0.43 | 1.29 |
Evodiamine | 0.42–42.00 | Y = 0.8719x − 0.1126 | 0.9998 | 0.0000 | 0.12 | 0.35 |
Rutaecarpine | 0.21–21.12 | Y = 5.5394x − 0.6834 | 0.9996 | 0.0000 | 0.06 | 0.17 |